These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22227028)

  • 1. Design of novel tyrosine-nitrogen mustard hybrid molecules active against uterine, ovarian and breast cancer cell lines.
    Descôteaux C; Brasseur K; Leblanc V; Parent S; Asselin E; Bérubé G
    Steroids; 2012 Apr; 77(5):403-12. PubMed ID: 22227028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAR study of tyrosine-chlorambucil hybrid regioisomers; synthesis and biological evaluation against breast cancer cell lines.
    Descôteaux C; Brasseur K; Leblanc V; Parent S; Asselin E; Bérubé G
    Amino Acids; 2012 Aug; 43(2):923-35. PubMed ID: 22102055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of D- and L-tyrosine-chlorambucil analogs active against breast cancer cell lines.
    Descôteaux C; Leblanc V; Brasseur K; Gupta A; Asselin E; Bérubé G
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7388-92. PubMed ID: 21051231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer.
    Saha P; Fortin S; Leblanc V; Parent S; Asselin É; Bérubé G
    Steroids; 2012 Sep; 77(11):1113-22. PubMed ID: 22801351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of new cyclic amidine analogs of chlorambucil.
    Bielawska A; Bielawski K; Muszyńska A
    Farmaco; 2004 Feb; 59(2):111-7. PubMed ID: 14871502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of estradiol-chlorambucil hybrids as anticancer agents.
    Gupta A; Saha P; Descôteaux C; Leblanc V; Asselin E; Bérubé G
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1614-8. PubMed ID: 20137939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of DNA damaging agents that form decoy binding sites for the estrogen receptor.
    Rink SM; Yarema KJ; Solomon MS; Paige LA; Tadayoni-Rebek BM; Essigmann JM; Croy RG
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15063-8. PubMed ID: 8986764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta.
    Descôteaux C; Leblanc V; Bélanger G; Parent S; Asselin E; Bérubé G
    Steroids; 2008 Oct; 73(11):1077-89. PubMed ID: 18572212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and antitumor properties of glycosylated antitumor ether lipid (GAEL)- chlorambucil-hybrids.
    Idowu T; Samadder P; Arthur G; Schweizer F
    Chem Phys Lipids; 2016 Jan; 194():139-48. PubMed ID: 26188768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues.
    Saha P; Descôteaux C; Brasseur K; Fortin S; Leblanc V; Parent S; Asselin E; Bérubé G
    Eur J Med Chem; 2012 Feb; 48():385-90. PubMed ID: 22209414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro efficacy of transferrin conjugates of the anticancer drug chlorambucil.
    Beyer U; Roth T; Schumacher P; Maier G; Unold A; Frahm AW; Fiebig HH; Unger C; Kratz F
    J Med Chem; 1998 Jul; 41(15):2701-8. PubMed ID: 9667961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological evaluation of novel estrogen-platinum(II) hybrid molecules on uterine and ovarian cancers-molecular modeling studies.
    Gagnon V; St-Germain ME; Descôteaux C; Provencher-Mandeville J; Parent S; Mandal SK; Asselin E; Bérubé G
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5919-24. PubMed ID: 15501069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linker structure-activity relationships in fluorodeoxyglucose chlorambucil conjugates for tumor-targeted chemotherapy.
    El Hilali M; Reux B; Debiton E; Leal F; Galmier MJ; Vivier M; Chezal JM; Miot-Noirault E; Coudert P; Weber V
    Bioorg Med Chem; 2017 Oct; 25(20):5692-5708. PubMed ID: 28927903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 17beta-estradiol-linked platinum(II) complexes and their cytocidal activity on estrogen-dependent and -independent breast tumor cells.
    Perron V; Rabouin D; Asselin E; Parent S; C-Gaudreault R; Bérubé G
    Bioorg Chem; 2005 Feb; 33(1):1-15. PubMed ID: 15668178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of triptolide from Tripterygium wilfordii on ERalpha and p53 expression in two human breast cancer cell lines.
    Liu J; Jiang Z; Xiao J; Zhang Y; Lin S; Duan W; Yao J; Liu C; Huang X; Wang T; Liang Z; Wang R; Zhang S; Zhang L
    Phytomedicine; 2009 Nov; 16(11):1006-13. PubMed ID: 19524422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of new prognostic markers, peripheral-type benzodiazepine receptor and carbonic anhydrase IX, in human breast and ovarian carcinoma cell lines.
    Hunakova L; Bodo J; Chovancova J; Sulikova G; Pastorekova S; Sedlak J
    Neoplasma; 2007; 54(6):541-8. PubMed ID: 17949239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines.
    Alao JP; Lam EW; Ali S; Buluwela L; Bordogna W; Lockey P; Varshochi R; Stavropoulou AV; Coombes RC; Vigushin DM
    Clin Cancer Res; 2004 Dec; 10(23):8094-104. PubMed ID: 15585645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines.
    Treeck O; Haldar C; Ortmann O
    Oncol Rep; 2006 Jan; 15(1):231-5. PubMed ID: 16328061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
    Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
    Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.